PNC Financial Services Group
AXSM icon

PNC Financial Services Group’s Axsome Therapeutics AXSM Stock Holding History

PNC Financial Services Group’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$454K Buy
2,461
+663
+37% +$144K ﹤0.01% 1900
2026
Q2 		$440K Sell
1,798
-282
-14% -$61.2K ﹤0.01% 1881
2026
Q1 		$352K Buy
2,080
+159
+8% +$27.5K ﹤0.01% 1939
2025
Q4 		$351K Buy
1,921
+65
+4% +$9.08K ﹤0.01% 1916
2025
Q3 		$225K Buy
1,856
+107
+6% +$12.1K ﹤0.01% 2222
2025
Q2 		$183K Sell
1,749
-3,920
-69% -$415K ﹤0.01% 2273
2025
Q1 		$661K Buy
5,669
+330
+6% +$37.6K ﹤0.01% 1355
2024
Q4 		$452K Sell
5,339
-90
-2% -$8.28K ﹤0.01% 1615
2024
Q3 		$488K Buy
5,429
+66
+1% +$5.76K ﹤0.01% 1549
2024
Q2 		$432K Sell
5,363
-22
-0.4% -$1.63K ﹤0.01% 1582
2024
Q1 		$430K Buy
5,385
+51
+1% +$4.28K ﹤0.01% 1632
2023
Q4 		$425K Sell
5,334
-17
-0.3% -$1.14K ﹤0.01% 1627
2023
Q3 		$374K Sell
5,351
-176
-3% -$13.2K ﹤0.01% 1679
2023
Q2 		$397K Buy
5,527
+135
+3% +$10K ﹤0.01% 1730
2023
Q1 		$333K Sell
5,392
-103
-2% -$6.77K ﹤0.01% 1805
2022
Q4 		$424K Sell
5,495
-105
-2% -$6.28K ﹤0.01% 1637
2022
Q3 		$250K Sell
5,600
-15,687
-74% -$784K ﹤0.01% 1941
2022
Q2 		$815K Buy
21,287
+35
+0.2% +$1.11K ﹤0.01% 1262
2022
Q1 		$879K Sell
21,252
-1
-0% -$31 ﹤0.01% 1310
2021
Q4 		$802K Sell
21,253
-42
-0.2% -$1.54K ﹤0.01% 1407
2021
Q3 		$703K Buy
21,295
+35
+0.2% +$1.36K ﹤0.01% 1410
2021
Q2 		$1.44M Buy
21,260
+32
+0.2% +$1.92K ﹤0.01% 1046
2021
Q1 		$1.2M Buy
21,228
+495
+2% +$34.8K ﹤0.01% 1084
2020
Q4 		$1.69M Hold
20,733
– – ﹤0.01% 903
2020
Q3 		$1.48M Hold
20,733
– – ﹤0.01% 884
2020
Q2 		$1.7M Buy
20,733
+19,733
+1,973% +$1.52M ﹤0.01% 832
2020
Q1 		$58K Hold
1,000
– – ﹤0.01% 2534
2019
Q4 		$104K Buy
+1,000
New +$40.4K ﹤0.01% 2469

Other funds holding AXSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

PNC Financial Services Group's AXSM Position: Q3 2026 in Review

PNC Financial Services Group increased its Axsome Therapeutics (AXSM) stake by 37% in Q3 2026, buying an estimated $144K and bringing the position to 2,461 shares worth $454K. The position accounts for ﹤0.01% of the portfolio, ranked #1900.

PNC Financial Services Group first reported a position in AXSM in Q4 2019 and has held it in 28 quarters since. The position peaked at $1.7M in Q2 2020. 235 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.

  • PNC Financial Services Group held 2,461 shares of Axsome Therapeutics worth $454K as of Q3 2026.
  • PNC Financial Services Group bought 663 Axsome Therapeutics shares in Q3 2026, an estimated $144K.
  • Axsome Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #1900 holding.
  • PNC Financial Services Group first reported a position in Axsome Therapeutics in Q4 2019 and has held it in 28 quarters since.
  • PNC Financial Services Group's Axsome Therapeutics position peaked at $1.7M in Q2 2020.
  • 235 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.